Should you buy, sell or hold Infosys, TCS, HCL Tech, BEL, PB Fintech, PNB Housing and other stocks in focus today?
Which stocks to buy, hold or sell today? As Dalal Street enters the April 3 session, heres a look at what brokerages make of some of the key stocks in focus. Stocks such as BEL, ONGC, PB Fintech, PNB Housing Finance, Infosys, TCS, Wipro, Tech Mahindra, and other IT shares are on their radar.
Which stocks to buy, hold or sell today? As Dalal Street enters the April 3 session, here's a look at what brokerages make of some of the key stocks in focus.
Stocks such as Bharat Electronics Limited (BEL), ONGC, PB Fintech, PNB Housing Finance, Infosys, TCS, Wipro, Tech Mahindra and other IT shares are on their radar today.
Do you have any of these stocks in your portfolio?
Check out the full list of what brokerages recommend, including IT shares, BEL, PB Fintech, PNB Housing Finance, Zydus Lifesciences and among other stocks:
Brokerages on IT stocks
Ahead of fourth-quarter results for the financial year 2022-23 (Q4FY23), global brokerages are upbeat on IT heavyweights such as HCL Technologies, Infosys, TCS, Wipro, and Tech Mahindra, recommending to ‘buy’ these shares.
HCL Technologies shares
Brokerage | Rating | Price Target |
CLSA | Outperform | Rs 1,200 |
Nomura | Neutral | Rs 1,150 |
HSBC | Buy | Rs 1,230 |
Macquarie | Outperform | Rs 1,580 |
Infosys shares
Brokerage | Rating | Price Target |
CLSA | Buy | Rs 1,800 |
Nomura | Buy | Rs 1,660 |
TCS shares
Brokerage | Rating | Price Target |
CLSA | Outperform | Rs 3,550 |
Nomura | Reduce | Rs 2,850 |
Tech Mahindra shares
Brokerage | Rating | Price Target |
CLSA | Outperform | Rs 1,200 |
Nomura | Buy | Rs 1,250 |
Wipro shares
Brokerage | Rating | Price Target |
CLSA | Outperform | Rs 450 |
Nomura | Neutral | Rs 380 |
PNB Housing Finance shares
Morgan Stanley maintained an ‘overweight’ stance on PNB Housing Finance with a target price of Rs 700 per share. The brokerage estimates that the base case profit after tax of the company would rise by 8-9 per cent for FY24-25, amid expected lower funding costs.
Zydus Lifesciences shares
Morgan Stanley also maintained an ‘overweight’ stance on Zydus Lifesciences with a target price of Rs 513 per share as the brokerage expects good earnings momentum for the company. It said core business and niche US opportunities like REcvilimind and Trokendi will aid growth.
PB Fintech shares
CLSA downgrade PB Fintech to ‘accumulate’ from ‘buy’ with an increased target price of Rs 710 per share from Rs 660 apiece earlier.
Bharat Electronics Limited (BEL) shares
CLSA has a ‘buy’ rating on Bharat Electronics with a revised target price of Rs 115 apiece. Similarly, Morgan Stanley retained an ‘overweight’ rating on BEL with a target of Rs 119
Brokerage | Rating | Price Target |
CLSA | Buy | Rs 115 |
Morgan Stanley | Overweight | Rs 119 |
According to CLSA, FY23 orders are in-line but execution below. It added while its specialty defense electronics firm has an impressive $7 billion 3-year backlog, it's set for large orders in FY24-26 from an over $15 billion nomination pipeline.
Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.